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AbsTrACT
Objective To assess the impact of hypothermic neural 
rescue for perinatal asphyxia at birth on healthcare 
costs of survivors aged 6–7 years, and to quantify the 
relationship between costs and overall disability levels.
Design 6–7 years follow-up of surviving children from 
the Total Body Hypothermia for Neonatal Encephalopathy 
(TOBY) trial.
setting Community study including a single parental 
questionnaire to collect information on children’s 
healthcare resource use.
Patients 130 UK children (63 in the control group, 67 
in the hypothermia group) whose parents consented and 
returned the questionnaire.
Interventions Intensive care with cooling of the body 
to 33.5°C for 72 hours or intensive care alone.
Main outcome measures Healthcare resource usage 
and costs over the preceding 6 months.
results At 6–7 years, mean (SE) healthcare costs per 
child were £1543 (£361) in the hypothermia group and 
£2549 (£812) in the control group, giving a saving of 
−£1005 (95% CI −£2734 to £724). Greater levels of 
overall disability were associated with progressively 
higher costs, and more parents in the hypothermia group 
were employed (64% vs 47%). Results were sensitive to 
outlying observations.
Conclusions Cost results although not significant 
favoured moderate hypothermia and so complement 
the clinical results of the TOBY Children study. Estimates 
were however sensitive to the care requirements of two 
seriously ill children in the control group. A quantification 
of the relationship between costs and levels of disability 
experienced will be useful to healthcare professionals, 
policy makers and health economists contemplating the 
long-term economic consequences of perinatal asphyxia 
and hypothermic neural rescue.
Trial registration number This study reports on the 
follow-up of the TOBY clinical trial: ClinicalTrials. gov 
number NCT01092637.
InTrODuCTIOn
A deficiency of oxygen at birth can result in injury 
to the neonatal brain. This neurological syndrome 
known as perinatal asphyxial encephalopathy can 
be characterised by the need for resuscitation, 
neurological depression and seizures, and is asso-
ciated with a high risk of death or early neuro-
developmental impairment.1 Initiating moderate 
hypothermia soon after delivery for 72 hours has 
been shown to reduce the risk of death or disability 
at 18–24 months of age, and to increase the rate of 
survival without disability.2 Long-term follow-up of 
children in three major trials of hypothermia (the 
Total Body Hypothermia for Neonatal Enceph-
alopathy (TOBY) trial, the CoolCap trial and the 
National Institute of Child Health and Human 
Development (NICHD) trial) has confirmed that 
the clinical benefit observed at 18 months persists 
or is maintained, at least in part, into middle 
childhood.3–5 
In addition to clinical data, the generation of data 
on the long-term cost impact of perinatal asphyxial 
encephalopathy and hypothermia is also crucial. 
Such data can provide clinicians and policy makers 
with vital information about the ongoing resources 
needed to provide care for survivors with disabil-
ities of varying severities. Long-term cost data are 
also necessary inputs into cost-effectiveness anal-
yses, which are paramount to ensure that scarce 
healthcare resources are appropriately invested in 
technologies that will realise most patient benefit. 
Indeed, cost-effectiveness analysis is now an inte-
gral part of the health technology appraisal process 
in many countries.6–8
The short-term cost-effectiveness of hypothermia 
for perinatal asphyxial encephalopathy has been 
modelled by synthesising outcome data from the 
TOBY, CoolCap and NICHD trials and using data 
on healthcare costs to 18 months from TOBY.9 
Acknowledging the long-term implications of the 
condition (which can include cerebral palsy, func-
tional disability and cognitive impairment), the 
authors presented a sensitivity analysis in which the 
time horizon for the analysis was extended from 
18 months to 18 years. In the absence of long-term 
What is already known on this topic?
 ► The benefits of hypothermic neural rescue in 
terms of cognitive and disability-free survival 
persist into middle childhood.
 ► Data on long-term costs following perinatal 
asphyxia and hypothermia have not previously 
been reported.
What this study adds?
 ► New comparative data on healthcare costs at 
6–7 years after hypothermia plus intensive care 
and intensive care alone for perinatal asphyxia.
 ► A quantification of healthcare costs by level of 
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data from neonatal encephalopathy survivors however, data on 
costs were taken from a cohort study of preterm infants and this 
was acknowledged as a limitation of the analysis.10 11
To address this lack of long-term data and as part of the 
6–7 years follow-up of surviving children in the TOBY trial, 
data were collected on children’s healthcare resource use and 
health-related quality of life (HRQoL).5 12 The objectives of this 
substudy were to describe resource use and costs at 6–7 years 




Parents of surviving children who participated in the original 
TOBY trial were invited to take part in the follow-up TOBY Chil-
dren study when their child reached 6–7 years.5 Detailed clinical 
findings from TOBY Children, which captured outcomes for 280 
of the 325 infants recruited to the original TOBY trial, are reported 
elsewhere.5 In brief, they showed at 6–7 years, when compared with 
the control group, a higher number of children in the hypothermia 
group survived with an IQ score ≥85 (52% vs 39%, relative risk 
(RR) 1.31, p=0.04), survived without neurological abnormalities 
(45% vs 28%, RR 1.60; 95% CI 1.15 to 2.22), and had significant 
reductions in the risk of cerebral palsy (21% vs 36%, p=0.03) and 
of moderate or severe disability (22% vs 37%, p=0.03).5
As part of that study, parents received a postal questionnaire 
including questions about the use of healthcare services by their 
child over the previous 6 months and the HRQoL Health Utili-
ties Index (results of which are reported elsewhere).13 The TOBY 
trial included centres from the UK, Sweden, Hungary, Finland 
and Israel, with UK centres contributing over 85% to the total 
sample size.
healthcare resource use and costs
The questionnaire contained a list of healthcare professionals 
and services likely to be used by TOBY Study children across 
primary, community and secondary care (column 1 of table 1). 
Parents recorded whether their child had any contact with each 
professional/service in the previous 6 months as well as the 
number of contacts. For contacts with hospitals, parents reported 
the reason, and the duration and ward type for any inpatient 
admissions. Parents could also report contacts with any other 
professionals (shown in column 1 of table 1 under the heading 
of 'Miscellaneous clinics/therapist sessions').
Table 1 Healthcare contacts included in the cost analysis and their associated unit costs (expressed in 2015/2016 UK pounds)
resource use item unit cost (£) source
Primary care:
  GP clinic consultation 36 Per typical 9.22 min consultation. Section 10.3b, Unit Costs of Health and Social Care 2016.14
  Practice nurse consultation 11 Per typical 15.5 min consultation. Section 10.2, Unit Costs of Health and Social Care 2016.14
Community care:
  Health visitor contact visit 59 Weighted average of Community Health Services Health Visitor and Midwifery (HVM) codes N03F and N03G. NHS 
Reference Costs 2015/2016.15
  Community nurse contact visit 112 Weighted average of Community Health Services Nursing (NURS) codes N06CF, N12 and N29CF. NHS Reference Costs 
2015/2016.15
  Community paediatrics contact visit 278 Community Paediatrics Outpatient Attendance (Code 290). NHS Reference Costs 2015/2016.15
  Optician contact visit 21 http://www.fodo.com/downloads/ofnc-sight-test-fee-statement---final.pdf35
  Orthoptist contact visit 58 Orthoptics Outpatient Attendance (Code 655). NHS Reference Costs 2015/2016.15
  Physiotherapist contact visit 87 Physiotherapist, Child, One to One Contact (Code A08C1). NHS Reference Costs 2015/2016.15
  Speech and language therapist contact 
visit
94 Speech and Language Therapist, Child, One to One Contact (Code A13C1). NHS Reference Costs 2015/2016.15
Secondary (hospital-based) care:
  A&E visit 187 Weighted average of all Emergency Medicine contact codes excluding cases DOA. NHS Reference Costs 2015/2016.15
  Hospital day unit attendance 749 Weighted average of Day Case Paediatric Admissions for Unexplained Symptoms in children with comorbid condition 
score 0 (code PX56B) and comorbid condition score 1+ (PX56A). NHS Reference Costs 2015/2016.15
  Hospital outpatient attendance 194 Paediatrics Outpatient Attendance (Code 420). NHS Reference Costs 2015/2016.15
  Hospital inpatient bed day 431 Weighted average of non-elective Excess Bed Day Costs across all paediatric codes. NHS Reference Costs 2015/2016.15
  Intensive care inpatient bed day 1173 Basic Paediatric Critical Care, code XB07Z. NHS Reference Costs 2015/2016.15
Miscellaneous clinics/therapist sessions:
  Occupational therapist contact visit 131 Occupational Therapist, Child, One to One Contact (Code A06C1). NHS Reference Costs 2015/2016.15
  Parent support worker/special 
educational needs worker contact visit
52 Per hour of client-related contact for a Family Support Worker. Section 11.8. Unit Costs of Health and Social Care 
2016.14
  Dietician contact visit 81 Community Health Services, Dietician Contact (Code A03). NHS Reference Costs 2015/2016.15
  Dentist contact visit 54 Per contact for a mid-band treatment (band 2). NHS Dental Charges. Section 10.7. Unit Costs of Health and Social Care 
2016.14
  Educational psychologist contact visit 85 Per hour of client-related contact. http://www3.hants.gov.uk/servicesforschools/education-psychology/education-
psychology-prices.htm.36
  Home Respite Team contact visit 24 Per family per hour for Home Support. Section 6.12 Short-break provision for disabled children and their families. Unit 
Costs of Health and Social Care 2016.14
  Social worker contact visit 79 Per hour of client-related contact for a Social Worker (Children’s Services). Section 11.3. Unit Costs of Health and Social 
Care 2016.14
  Support for physical disability contact 
visit
24 Per family per hour for Home Support. Section 6.12 Short-break provision for disabled children and their families. Unit 
Costs of Health and Social Care 2016.14
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For each child, costs were estimated by multiplying the 
numbers and/or durations recorded for each type of contact 
by appropriate unit costs obtained primarily from national 
sources.14 15 These unit costs are also shown in table 1, expressed 
in 2015–2016 UK Pound Sterling.
statistical analysis
It is accepted that clinical practice, healthcare resource use and 
unit costs can vary between countries, and so simply aggre-
gating multinational data for a cost analysis will likely generate 
findings that are not meaningful or representative to any one 
country.16 17 In view of this and with 89.7% of questionnaire 
responses received from the UK (9.7% were from Hungary, and 
0.6% from Finland), only UK data were used for the analysis.
Mean (SE) healthcare contact and cost data were summarised 
for each trial arm and compared using mean differences and 95% 
CIs. Data were right skewed but as parametric and non-para-
metric CIs were similar, only parametric intervals are reported.18
Data were missing for 11.5% of healthcare contacts and were 
assumed to be missing at random. Two types of missingness were 
identified: one, whereby the type of contact was recorded but 
the number of contacts was missing, the other where data on 
both the type and number of contacts were missing. Multiple 
imputation (MI) using chained equations was used to impute 
missing values (see online supplementary appendix).19 20 The 
base-case cost results were generated using the MI data, with 
Rubin’s rule used to generate combined estimates of means and 
SEs across MI datasets.21
In addition to the comparative cost analysis, the relationship 
between total healthcare costs and overall disability levels at 6–7 
years was explored. Given the skewness in the data, a gener-
alised gamma model with a log link function was used to regress 
total costs against overall disability levels (none, mild, moderate 
and severe—see footnote to table 2 for level descriptions), while 
controlling for trial arm and characteristics at trial entry (delivery 
complications at birth (yes/no), gestational age at birth (weeks), 
birth weight (g) and gender). A modified Park test was used to 
confirm the appropriateness of the gamma model.22 23 Rubin’s 
rule was also implemented to generate the combined regression 
coefficients and associated SEs across MI datasets.
All analyses were conducted in Stata MP V.13 (Stata Statistical 
Software, 2013, StataCorp, College Station, Texas, USA).
sensitivity analysis
Sensitivity analysis explored the significance of outlying observa-
tions; two children in the control arm spent considerably more 
nights in hospital than other children requiring inpatient care. In 
a first analysis, the two children were removed and in a second 
analysis, their days in hospital were replaced by the longest 




Figure 1 shows the flow of children through the study. Of the 
229 TOBY trial survivors at 6–7 years, 184 (80%) parents/carers 
consented to participate in the main TOBY Children study and 
45 (20%) were lost to follow-up. One hundred and forty-five of 
the 184 consenting parents (79%) returned the study question-
naire and 39/184 (21%) either did not respond or declined the 
questionnaire. The 130/145 (90%) responses from the UK form 
the sample for this study.
Sixty-seven children were from the hypothermia arm and 63 
from the control arm. There were no differences between arms 
with regard to baseline demographics or clinical characteristics 
at trial entry (table 2). Differences in clinical outcomes at 6–7 
years were comparable to those observed for survivors in the 
wider TOBY Children study population; a higher proportion 
of children in the hypothermia group had normal neurological 
functioning and an IQ score ≥ 85, and fewer had moderate or 
severe levels of disability. More carers were in employment in 
the hypothermia group.
There were no differences between the 145 children whose 
parents returned the study questionnaire and the subsample of 
130 UK children (online supplementary appendix table A1). 
There were also no differences between the 130 UK children and 
the 39 children whose parents consented to the study but did not 
return the questionnaire (online supplementary appendix table 
A1). Among these 39 non-responding families (and as observed 
for the responding families), a higher proportion of children in 
the hypothermia group had an IQ≥85 (16/23 (70%) vs 9/16 
(56%), p=0.394) and had normal neurological functioning 
(14/23 (61%) vs 6/16 (38%), p=0.151).
Of the 45/229 (20%) surviving children who were lost to 
follow-up, 18 (40%) were in the hypothermia arm and 27 (60%) 
were in the control arm.5 When compared with surviving chil-
dren for whom primary outcome data were available, those lost 
to follow-up had a higher frequency (although not statistically 
significantly so) of severe abnormalities on amplitude-integrated 
electroencephalogram (EEG) at trial entry, and lower scores on 
the Mental Development Index at 18 months.5
health service resource use and associated costs
Base-case mean healthcare contacts and costs estimated using the 
multiple imputation data are summarised in table 3 (additional 
details of the missing data, and the impact of multiple imputa-
tion are discussed in the online supplementary appendix, tables 
A2–A4).
For many of the healthcare contacts, mean usage and costs 
were similar in both trial arms (table 3). In contrast, inpatient 
admission costs were noticeably lower in the hypothermia 
group (mean difference −£817 (−£2141 to £508)). Although 
the proportion of children with at least one hospital inpatient 
admission in each arm was similar (11.1% vs 10.8%), in the 
control arm the mean total time in hospital was greater (19.9 vs 
6.6 days) due to two children spending a total of 53 and 58 days 
in hospital (see online supplementary appendix table A4). One 
admission for epilepsy required a prolonged stay (14 days) in 
intensive care.
Children in the control group also appeared to need greater 
input from other specialists. The mean cost difference for these 
‘other’ services favoured the hypothermia group at −£245 
(−£555 to £64), but was not statistically significant.
The total mean NHS cost per child over the 6-month period 
was £2549 (£812) in the control group and £1543 (£361) in the 
hypothermia group, giving a non-statistically significant differ-
ence of −£1005 (−£2734 to £724) favouring hypothermia.
Costs and disability levels
When modelling costs, the modified Park test showed the gamma 
model to be most appropriate when compared with models using 
Poisson, inverse Gaussian and Gaussian distributions. Table 4 
shows the estimated coefficients from the regression model. The 
multiplicative effect of each coefficient is also reported. The coef-
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Table 2 Child demographics, clinical characteristics and neurological function at 6–7 years by trial arm, for surviving children in the UK with 
questionnaire data. Also shown are parental socioeconomic characteristics
Control group (n=63) hypothermia group (n=67) P values
Baseline demographics and characteristics at trial entry
  Male sex, n (%): 34 (54) 42 (63) 0.31
   Missing 0 0
  Age (years)
   Median (IQR) 6.2 (6.1–6.5) 6.3 (6.1–6.9) 0.37
   Missing 3 1
  Gestational age (weeks):
   Median (IQR) 40 (39-41) 40.3 (39.3–41.4) 0.33
   Missing 4 0
  Birth weight (g):
   Median (IQR) 3400 (3194–3930) 3450 (3175–3838) 0.81
   Missing 0 0
  Delivery complications, n (%): 46 (74) 51 (76) 0.80
   Missing 1 0
  Apgar score≤5 at 10 min, n (%): 38 (72) 39 (72) 0.95
   Missing 10 13
Outcomes at 6–7 years
  Normal neurological function, n (%) 31 (49) 46 (69) 0.02
   Missing 0 0
  IQ≥85, n (%) 40 (67) 54 (81) 0.07
   Missing 3 0
  Overall disability*, n (%):
   None 27 (43) 49 (75) <0.001
   Mild 10 (16) 4 (6)
   Moderate 8 (13) 4 (6)
   Severe 18 (29) 8 (12)
   Missing 0 2
Parental socioeconomic characteristics at 6–7 years
  Main carer highest qualification, n (%): 0.81
   None of the below 2 (3) 5 (7)
   Vocational qualification NVQ or CSE 9 (15) 9 (13)
   O Level, GCSE or Scottish Standards 14 (23) 11 (16)
   BTEC, A Levels or Scottish Highers 6 (10) 6 (9)
   Diploma or HND 6 (10) 11 (16)
   University degree 12 (20) 15 (22)
   Postgraduate university degree 10 (16) 9 (13)
   Other qualification 2 (3) 1 (1)
   Missing 2 0
  Main carer employment, n (%): 0.02
   Employed 22 (36) 41 (61)
   Self-employed 7 (11) 2 (3)
   Unemployed 14 (23) 10 (15)
   Other† 18 (30) 14 (21)
   Missing 2 0
  Main carer home, n (%): 0.89
   Owner (mortgage) 40 (63) 43 (64)
   Council rented 11 (17) 7 (10)
   Private rented (furnished) 3 (5) 2 (3)
   Private rented (unfurnished) 3 (5) 11 (16)
   Housing society or co-operative 3 (5) 1 (1)
   Other‡ 3 (5) 3 (4)
   Missing 0 0
*Overall disability—mild disability (an IQ score of 70–84, level 1 gross motor function (is able to walk independently but may have some gait abnormalities), or abnormality in one or 
both eyes with normal or nearly normal vision); moderate disability—(an IQ score of 55–69, level 2 or 3 gross motor function (has minimal ability to perform gross motor skills or requires 
assistance with walking), or moderately reduced vision); severe disability (an IQ score of <55, level 4 or 5 gross motor function (needs adaptive seating or has severely limited mobility), or no 
useful vision).
†Open-ended question (responses included housewife, carer, etc).
‡Open-ended question.
 A Level, advanced level; BTEC, Business and Technology Education Council; CSE, Certificate of Secondary Education; HND, Higher National Diploma; O Level, ordinary level; GCSE, General 
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for moderate and severe levels are statistically significantly greater 
than the reference category of no disability. The model was used to 
estimate mean total healthcare costs for each of the four disability 
levels for an average child in the TOBY trial (a male, born at 40 
weeks, having delivery complications, a birth weight of 3400 g and 
receiving hypothermia) (see online supplementary appendix for 
the approach used). The resulting estimated mean total cost for 
a child with no disabilities was £450, with mild disabilities was 
£1043 (95% CI £363 to £2998), with moderate disabilities was 
£5651 (95% CI £1715 to £18 624) and with severe disabilities was 
£12 335 (95% CI £5238 to £29 049).
sensitivity analysis
Excluding the two children in the control arm who each spent 
>50 days in hospital had a substantial impact on the comparative 
cost results. Figure 2 shows how the mean total cost difference of 
−£1005 favouring hypothermia disappeared and the mean cost 
saving in secondary care of −£834 was replaced by a cost increase 
of £157. Retaining both children but replacing their time in 
hospital with 20 days reduced the mean secondary care cost differ-
ence from −£834 to −£184 and the mean total cost difference 
by two-thirds from −£1005 to −£355 in favour of hypothermia.
Re-estimating the regression model after removing the two 
outlying children reduced the coefficient for the severe disability 
level from 3.31 to 2.68, that is, relative to a child with no disability, 
costs for a child with a severe disability were estimated to be 14 
times greater rather than 27 times greater as in the base-case anal-
ysis (table 4).
DIsCussIOn
This study is the first to offer a comparative assessment of 
primary, community and secondary sector healthcare costs 
in children aged 6–7 years after randomisation to standard 
care with hypothermia or standard care alone, for perinatal 
asphyxia. On average, those randomised to hypothermia had 
lower although non-statistically significant total healthcare costs 
during the previous 6 months. As the follow-up of a randomised 
trial and using a sample size fixed from the original trial, we 
were underpowered to detect statistically significant differences 
in costs. This is not unusual for clinical trials which are routinely 
powered on clinical outcomes. When considered alongside the 
main clinical outcomes from the TOBY Children study, the 
direction of the cost figures in favour of hypothermia appears 
intuitive.5
Results were highly sensitive to the hospital inpatient length 
of stays of two children in the control group. Both had severe 
neurodevelopmental disability and multiple handicaps and spent 
considerably more days in hospital than any other children in 
the study. During the 6-month recall period, total healthcare 
costs for these two children amounted to £26 477 and £40 129 
and demonstrate that the needs of children with multiple severe 
sequelae can be substantial.
Whether the magnitude of the cost differential between trial 
arms is representative, will depend on whether the care require-
ments for these two children are typical. During the 6-month 
study period, we may have captured unusually severe manifes-
tations of their chronic conditions, which if used as the basis of 
long-term cost extrapolations, could lead to erroneous predic-
tions. For policy makers and health economists, the 6-month 
time horizon used in this study is a limiting factor and the uncer-
tainties arising as a consequence of this should be borne in mind.
Few comparable estimates of long-term resource use for 
this patient group have been reported. The NICHD follow-up 
study reported comparative data on the proportion of children 
receiving speech therapy at 6–7 years, but not on the number 
of contacts that took place.24 The proportions for the hypo-
thermia and control groups of 30% and 43%, respectively were 
not dissimilar to those observed for speech and language therapy 
in this study; 25% (15/59) in the hypothermia arm and 48% 
(28/58) in the control arm.
We followed convention for modelling costs and used a gener-
alised gamma model with a log link function when exploring 
the relationship between healthcare costs and disability levels.25 
Relative to children with no disability, progressively higher costs 
were incurred by those with mild, moderate and severe disabili-
ties. Findings were again sensitive to the two outlying children; in 
their absence, costs for a child with a severe disability were esti-
mated to be 14 times greater than for a child with no disability, 
rather than 27 times greater as in the base-case analysis.
Our analysis has a number of limitations. First, the perspec-
tive for the costing work was restricted to the health service and 
excluded costs borne by the family and wider society. Table 2 
showed that fewer parents of children in the control group were 
in paid employment, probably because of the demands of caring 
for an unwell child.26 This likely translates into a reduction of 
family income and an increase in expenses required to improve 
the comfort of the child.26–28 Furthermore, the caregiving burden 
often does not reduce as the child grows and can also impact the 
health of main carers.26 29–34 With this in mind and had it been 
Figure 1 Flow of children through the study. TOBY, Total Body 
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possible to extend the perspective of this analysis from one of 
the health service to wider society, the findings reported here 
would likely have been strengthened.
Second, these analyses used a subsample (130/184, 71%) of 
UK data from the 184 parents who consented to participate in 
the 6–7 years TOBY Children follow-up study. Analyses showed 
no significant differences between children whose parents 
completed the questionnaire in the UK, and in non-UK coun-
tries. There were also no differences between the 130 UK chil-
dren used in the analysis, and the 39 children whose parents 
consented but did not return the questionnaire. Furthermore, 
and when looking between trial arms at differences in clinical 
outcomes for children in responding and non-responding fami-
lies, the direction and magnitude of the differences observed 
were not dissimilar. Had these 39 children been included in the 
analysis, one might hypothesise that the findings would not have 
altered substantially.
Third, it is important to consider the implications for the 
cost results, had it been possible to include the 45/229 (20%) 
surviving TOBY Children lost to follow-up. These children had 
more severe abnormalities on EEG at trial entry and lower scores 
Table 3 Base-case mean (SE) healthcare resource use and cost (UK £ 2015/2016) by trial arm, and mean differences (95% CI) between trial arms 

















  GP clinic visits 1.46 (0.24) 1.37 (0.26) −0.09 (–0.79 to 0.60) £52 (£8) £49 (£9) –£3 (–£28 to £22)
  Practice nurse visits 0.12 (0.04) 0.35 (0.13) 0.23 (–0.05 to 0.51) £1 (£0) £4 (£1) £3 (–£1 to £6)
Total cost—primary care – – – £54 (£9) £53 (£10) –£1 (–£27 to £26)
Community care
  Health visitor visits 0.06 (0.06) 0.18 (0.08) 0.12 (–0.09 to 0.33) £3 (£4) £11 (£5) £7 (–£5 to £20)
  Community nurse visits 0.80 (0.33) 0.85 (0.50) 0.05 (–1.16 to 1.26) £89 (£37) £95 (£56) £6 (–£130 to £141)
  Community paediatrics visits 0.29 (0.09) 0.57 (0.21) 0.28 (–0.19 to 0.75) £81 (£26) £159 (£59) £78 (–£52 to £208)
  Optician visits 0.27 (0.07) 0.45 (0.13) 0.17 (–0.12 to 0.47) £6 (£1) £10 (£3) £4 (−£3 to £10)
  Orthoptist visits 0.30 (0.10) 0.25 (0.12) −0.06 (–0.36 to 0.25) £17 (£6) £14 (£7) –£3 (–£21 to £14)
  Physiotherapist visits 3.07 (0.89) 2.46 (1.11) −0.61 (–3.54 to 2.33) £268 (£78) £215 (£97) –£53 (–£309 to £203)
  SALT visits 2.64 (0.71) 3.03 (1.47) 0.39 (–2.95 to 3.74) £249 (£67) £287 (£139) £37 (–£279 to £353)
Total cost—community care – – – £715 (£159) £790 (£235) £75 (–£504 to £655)
Secondary (hospital-based) care:
  A&E visits 0.42 (0.16) 0.19 (0.06) −0.23 (–0.55 to 0.09) £78 (£29) £35 (£11) –£43 (–£103 to £17)
  Hospital day unit visits 0.10 (0.07) 0.14 (0.07) 0.04 (–0.15 to 0.22) £75 (£51) £101 (£49) £27 (–£114 to £167)
  Hospital outpatient visits 0.87 (0.26) 0.87 (0.22) −0.01 (–0.67 to 0.65) £170 (£50) £169 (£44) –£1 (–£129 to £127)
  Hospital inpatient days 2.21 (1.25) 0.69 (0.38) −1.51 (–4.04 to 1.01) £1116 (£668) £299 (£163) –£817 (–£2141 to £508)
Total cost—secondary care – – – £1438 (£732) £604 (£199) –£834 (–£2295 to £627)
Other miscellaneous clinics/therapist sessions†:
  Occupational therapist visits 1.14 (0.55) 0.50 (0.24) −0.64 (–1.81 to 0.53) £149 (£72) £65 (£32) –£84 (–£237 to £69)
  Parent support worker/special 
educational needs worker
1.02 (0.82) 0.24 (0.14) −0.78 (–2.38 to 0.83) £53 (£42) £12 (£7) –£40 (–£124 to £43)
  Dietician visits 0.05 (0.05) 0.10 (0.07) 0.06 (–0.11 to 0.22) £4 (£4) £8 (£6) £5 (–£9 to £18)
  Dentist visits 0.02 (0.02) 0.04 (0.03) 0.03 (–0.03 to 0.09) £1 (£1) £2 (£1) £2 (–£2 to £5)
  Educational psychologist visits 0.02 (0.02) 0.01 (0.01) −0.00 (–0.04 to 0.04) £1 (£1) £1 (£1) £0 (–£4 to £4)
  Home respite team visits 0.38 (0.38) 0.00 (0.00) −0.38 (–1.11 to 0.35) £73 (£73) £0 (£0) −£73 (−£213 to £67)
  Social worker visits 0.00 (0.00) 0.09 (0.09) 0.09 (–0.09 to 0.27) £0 (£0) £7 (£7) £7 (–£7 to £22)
  Support for physical disability visits 0.32 (0.32) 0.00 (0.00) −0.32 (–0.93 to 0.29) £61 (£61) £0 (£0) –£61 (–£178 to £56)
Total cost—miscellaneous clinics/therapist 
sessions
– – – £342 (£157) £97 (£35) –£245 (–£555 to £64)
Total overall cost – – – £2549 (£812) £1543 (£361) –£1005 (–£2734 to £724)
The bold values identify the total costs for each cost category (eg, primary care, community care etc) and for overall total costs. 
*Base-case results estimated using imputed data.
†Other miscellaneous clinics/therapist sessions are from a section of the questionnaire which was optional to complete. If respondents did not complete this section, we have assumed no contacts 
took place.
A&E, accident and emergency; GP, general practitioner; SALT, speech and language therapy. 
Table 4 Generalised linear regression equation (gamma model 
with a log link) of the relationship between total healthcare costs and 
overall disability levels (n=125 UK children)*
Variable Coefficient se P values
Multiplicative 
effect
Trial arm† 0.552 0.374 0.140 1.74
Delivery complications‡ 0.597 0.390 0.126 1.82
Gestational age −0.145 0.121 0.230 0.87
Birth weight −0.0002 0.0003 0.393 1.00
Male gender§ −0.286 0.336 0.395 0.75
Mild disability¶ 0.841 0.538 0.119 2.32
Moderate disability¶ 2.531 0.60 0.000 12.56
Severe disability¶ 3.311 0.437 0.000 27.43
Constant 11.850 4.471 0.008 –
*Five children were missing characteristics at trial entry and were excluded from 
the model.
†Hypothermia arm relative to base category of control arm.
‡Relative to base category of no delivery complications.
§Relative to base category of female.
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on the Mental Development Index at 18 months.5 Based on the 
results in table 4 which showed higher costs accompany higher 
levels of disability, one can hypothesise that the mean cost esti-
mates reported here would likely be greater had data from these 
children been available. With two-fifths of the 45 children in the 
hypothermia arm, and three-fifths in the control arm, it is also 
likely that the magnitude of the cost difference favouring hypo-
thermia would increase.
Fourth, the study relied on parents recalling healthcare 
contacts over the previous 6 months. We acknowledge that data 
for the analysis could have been obtained from routine national 
secondary sources; however, this approach had both cost and 
time implications and would also probably not have yielded the 
same richness of data provided by parents on additional care 
inputs required by their children (eg, respite carers, educational 
psychologists). Finally, some resource use data were missing and 
imputation of these data had a noticeable impact on a small 
number of cost categories. However, the magnitude and direc-
tion of changes were intuitive given the nature of the missing 
data and the observed distributions of complete data which 
informed the imputed values.
COnClusIOns
This study is the first to report primary, community and 
secondary healthcare costs in children surviving 6–7 years after 
randomisation to hypothermia or standard care alone for peri-
natal asphyxia. Hypothermia was associated with lower costs, 
although the reduction did not achieve statistical significance 
and was sensitive to outlying observations. The study has also 
been able to quantify how healthcare costs increase with greater 
levels of disability and we believe this information will be both 
important and useful to those involved in planning patient care. 
In conclusion, this work provides previously unavailable data of 
interest to clinicians, health policy makers and health economists 
who may now wish to re-evaluate the long-term economic conse-
quences of hypothermia for perinatal asphyxia.
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